135 related articles for article (PubMed ID: 16404234)
1. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
[TBL] [Abstract][Full Text] [Related]
2. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
3. Estimation of 99mTc-MAG3 clearance by single-sample methods and camera-based methods.
Inoue Y; Yoshikawa K; Yokoyama I; Ohtomo K
Ann Nucl Med; 2000 Oct; 14(5):329-32. PubMed ID: 11108160
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method.
Werner E; Blasl C; Reiners C
J Nucl Med; 1998 Jun; 39(6):1066-9. PubMed ID: 9627345
[TBL] [Abstract][Full Text] [Related]
5. Administered activity optimization in 99mTc-MAG3 renography for adults.
Díaz MP; Aparicio EE; Rizo OD; Díaz RR; Rodríguez CH
J Nucl Med Technol; 2003 Dec; 31(4):216-21. PubMed ID: 14657288
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian 3-compartment model for 99mTc-MAG3 clearance.
Russell CD
J Nucl Med; 2003 Aug; 44(8):1357-61. PubMed ID: 12902428
[TBL] [Abstract][Full Text] [Related]
7. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity.
Nimmon CC; Sámal M; Britton KE
J Nucl Med; 2004 Apr; 45(4):587-93. PubMed ID: 15073254
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
[TBL] [Abstract][Full Text] [Related]
10. Plasma clearance of 99Tcm-MAG3: accuracy of five single-sample methods.
Rehling M; Nielsen LE
Nucl Med Commun; 2000 Feb; 21(2):193-7. PubMed ID: 10758616
[TBL] [Abstract][Full Text] [Related]
11. Radiopharmacokinetics, renal clearance and dosimetry of 99mTc-MAG3.
Arteaga de Murphy C; Molina-Trinidad E; Meléndez-Alafort L; Ferro-Flores G; Reyes-Herrera L; Sepúlveda-Méndez J; Sandoval-Guzmán B; Hoyo-Vadillo C
Arch Med Res; 1999; 30(1):49-54. PubMed ID: 10071425
[TBL] [Abstract][Full Text] [Related]
12. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
13. Monitoring renal function: a prospective study comparing camera-based technetium-99m mercaptoacetyltriglycine clearance and creatinine clearance.
Halkar R; Taylor A; Manatunga A; Issa MM; Myrick SE; Grant S; Shenvi NV
Urology; 2007 Mar; 69(3):426-30. PubMed ID: 17382136
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of the reproducibility of Technetium-99m mercaptoacetyltriglycine clearance.
De Sadeleer C
Nucl Med Rev Cent East Eur; 2005; 8(1):15-20. PubMed ID: 15977142
[TBL] [Abstract][Full Text] [Related]
15. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the uptake method for estimating renal clearance of 99mTc mercaptoacetyltriglycine.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Usui K; Kikuchi K; Kaneko S; Yachiku S; Sasajima T; Aburano T
Nucl Med Commun; 2004 Feb; 25(2):159-66. PubMed ID: 15154706
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance.
Piepsz A; Tondeur M; Kinthaert J; Ham HR
Eur J Nucl Med; 1996 Feb; 23(2):195-8. PubMed ID: 8925855
[TBL] [Abstract][Full Text] [Related]
18. Prediction of two-sample (99m)Tc-diethylene triamine pentaacetic acid plasma clearance from single-sample method.
Zuo L; Ying-Chun ; Wang M; Zhang CL; Wang RF; Wang HY
Ann Nucl Med; 2005 Jul; 19(5):399-405. PubMed ID: 16164197
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling.
Inoue Y; Ohtomo K
Clin Nucl Med; 2011 Nov; 36(11):1012-6. PubMed ID: 21975390
[TBL] [Abstract][Full Text] [Related]
20. Recovery of renal retention function by differentiating the Patlak-Rutland plot.
Kuyvenhoven JD; Ham HR; Piepsz A
Nucl Med Commun; 2004 May; 25(5):501-7. PubMed ID: 15100510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]